Expanding horizons: Why ophthalmology practices should consider embracing clinical trials

In this article with Ocular Surgery News, Lexitas Chief Medical Officer, David Tanzer, MD, ABO, outlines the advantages of becoming a clinical trial site and the steps you can take to get started.

Our Visionary Insights newsletter is published once a month and has thousands of subscribers. To stay in touch, subscribe today.